silicon phthalocyanine
Small moleculeexperimentalImaging agent
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2001 (NCT00023790)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cl2sipc
- dichlorosilicon phthalocyanine
- hosipcosi(ch3)2(ch2)3n(ch3)2
- nsc 676418
- silicon phthalocyanine
- silicon phthalocyanine
- silicon phthalocyanine
- silicon phthalocyanine pc4
- sipc iv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07089368 | N/A | Jul 31, 2025 | University of Brescia |
| NCT04374383 | Phase 2 | Jun 1, 2019 | SVS Institute of Dental Sciences |
| NCT01800838 | Phase 1 | Apr 1, 2013 | Case Western Reserve University, National Cancer Institute (NCI) |
| NCT00103246 | Phase 1 | Sep 1, 2004 | Case Western Reserve University, National Cancer Institute (NCI) |
| NCT00023790 | Phase 1 | Aug 1, 2001 | Case Western Reserve University, National Cancer Institute (NCI) |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 3 | 3 | 1 | 2001 |
| National Cancer Institute (NCI) | Government | 3 | 0 | 1 | 2001 |
| SVS Institute of Dental Sciences | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Brescia | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1